Mediq B.V. entered into an agreement to acquire DiaExpert GmbH from Ypsomed Holding AG (SWX:YPSN) on October 27, 2022. The acquisition is subject to regulatory approval and is expected to be completed in the upcoming months. January 3, 2023, All authorizations were obtained at the end of last year. Heike Wagner, Tobias Kilian, Roland Wiring, Stefan Lehr, Michael Kamps, Jörg Schrade, Dirk Smielick and Boris Alles of CMS Hasche Sigle Partnerschaft von Rechtsanwälten und Steuerberatern mbB acted as legal advisor to Ypsomed.

Mediq B.V. completed the acquisition of DiaExpert GmbH from Ypsomed Holding AG (SWX:YPSN) for CHF17 million on January 3, 2023.